Intermolecular appoints Chris Kramer president and CEO
Mr. Kramer has more than 25 years of experience as a senior technology executive in the semiconductor and materials industry in the U.S., Asia and Europe.
He joined ATMI in 2010 as Senior Vice President of Materials Solutions, where he was responsible for the company's ion implant business operations and its gas and liquid storage and delivery systems. In 2013, he was promoted to manage ATMI's microelectronics materials business as its General Manager.
Subsequently, he joined Entegris in 2014 as part of the ATMI acquisition. He served the company as Senior Vice President and General Manager of Electronic Materials, and as the Chief Commercial Officer.
Prior to joining ATMI, Mr. Kramer was Vice President, Global Strategic Account Management, for Tokyo Electron America (TEL), where he was responsible for developing and maximizing strategic business and technology relationships with IBM and their alliance partners.
Mr. Kramer received a B.S. degree from the U.S. Naval Academy and served in the U.S. Navy as a Surface Warfare Officer for seven years after receiving his degree and commission.
Bruce McWilliams will assume the role of Executive Chairman. ■
LATEST MOVES FROM California
- Reed's appoints Stefan Freeman as interim CEO
- Heron Therapeutics appoints Robert E. Hoffman as CFO
- Penumbra appoints Bridget O'Rourke to board
- Adverum Biotechnologies adds Richard N. Spivey to board
- Lombard Medical appoints Kurt Lemvigh as CEO
More inside POST
Creative staff lead to satisfied customers Leadership